Associations of serum uric acid and gamma-glutamyltransferase with cancer in the Vorarlberg Health Monitoring and Promotion Programme (VHM&PP) - A short review

Memo - Magazine of European Medical Oncology

Volumn 4, Issue 1, 2011, Pages 50-54

  Edlinger, M ^a   Nagel, G ^b   Hilbe, W ^a   Diem, G ^c   Concin, H ^c   Strasak, Alexander M ^a   Ulmer, H ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF ULM   (Germany)

^c AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

Author keywords

Cancer; Epidemiology; Gamma glutamyltransferase; Prospective cohort study; Serum uric acid

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; URIC ACID;

CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CORRELATIONAL STUDY; DISEASE MARKER; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEALTH PROGRAM; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; METABOLIC SYNDROME X; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SEX DIFFERENCE; URIC ACID BLOOD LEVEL;

EID: 79956190448     PISSN: 18655041     EISSN: 18655076     Source Type: Journal    
DOI: 10.1007/s12254-011-0249-4     Document Type: Review

References (35)

1. JT Beard 1983 Serum uric acid and coronary heart disease Am Heart J 106 397 400 6869223 10.1016/0002-8703(83)90209-0
2. W Koenig C Meisinger 2008 Urid acid, type 2 diabetes, and cardiovascular diseases: fueling the common soil hypothesis? Clin Chem 54 231 233 18223129 10.1373/clinchem.2007.099705 1:CAS:528:DC%2BD1cXhs1Cmtbc%3D (Pubitemid 351302613)
3. D Conen V Wietlisbach P Bovet C Shamlaye W Riesen F Paccaud M Burnier 2004 Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country BMC Public Health 4 9 15043756 10.1186/1471-2458-4-9 1:STN:280:DC%2BD2c3js1CksA%3D%3D
4. BN Ames R Cathcart E Schweirs P Hochstein 1981 Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis Proc Natl Acad Sci U S A 78 6858 6862 6947260 10.1073/pnas.78.11.6858 1:CAS:528:DyaL38Xks1Gg (Pubitemid 12216861)
5. RA Hiatt BH Fireman 1988 Serum uric acid unrelated to cancer incidence in humans Cancer Res 48 2916 2918 3359448 1:CAS:528:DyaL1cXktVCltLc%3D
6. LN Kolonel C Yoshizawa AM Nomura GN Stemmermann 1994 Relationship of serum uric acid to cancer occurrence in a prospective male cohort Cancer Epidemiol Biomarkers Prev 3 225 228 8019371 1:STN:280:DyaK2c3ptVaksA%3D%3D (Pubitemid 24172535)
7. JB Whitfield 2001 Gamma glutamyl transferase Crit Rev Clin Lab Sci 38 263 355 11563810 10.1080/20014091084227 1:CAS:528:DC%2BD3MXnt1Git7c%3D (Pubitemid 32826505)
8. DH Lee MH Ha S Kam B Chun J Lee K Song Y Boo L Steffen DR Jacobs Jr. 2006 A strong secular trend in serum gamma-glutamyltransferase from 1996 to 2003 among South Korean men Am J Epidemiol 163 57 65 16293720 10.1093/aje/kwj006 (Pubitemid 43007115)
9. A Pompella M Emdin C Passino A Paolicchi 2004 The significance of serum gamma-glutamyltransferase in cardiovascular diseases Clin Chem Lab Med 42 1085 1091 15552264 10.1515/CCLM.2004.224 1:CAS:528:DC%2BD2cXpslOht7Y%3D (Pubitemid 39481146)
10. DS Lee JC Evans SJ Robins PW Wilson I Albano CS Fox TJ Wang EJ Benjamin RB D'Agostino RS Vasan 2007 Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham heart study Arterioscler Thromb Vasc Biol 27 127 133 17095717 10.1161/01.ATV.0000251993. 20372.40 1:CAS:528:DC%2BD28XhtlSrsb%2FO (Pubitemid 46360389)
11. E Ruttmann LJ Brant H Concin G Diem K Rapp H Ulmer 2005 The Vorarlberg health monitoring and promotion programme study group. γ- Glutamyltransferase as a risk factor for cardiovascular disease mortality, an epidemiological investigation in a cohort of 163 944 Austrian adults Circulation 112 2130 2137 16186419 10.1161/CIRCULATIONAHA.105.552547 1:CAS:528: DC%2BD2MXhtVCltrfK (Pubitemid 41475806)
12. A Pompella V De Tata A Paolicchi F Zunino 2006 Expression of gamma-glutamyltransferase in cancer cells and its significance in drug resistance Biochem Pharmacol 71 231 238 16303117 10.1016/j.bcp.2005.10.005 1:CAS:528:DC%2BD2MXhtlCqur%2FP (Pubitemid 41817283)
13. DH Lee DR Jacobs Jr. 2006 Association between serum concentrations of persistent organic pollutants and glutamyltransferase: results from the National Health and Examination Survey 1999-2002 Clin Chem 52 1825 1827 16940464 10.1373/clinchem.2006.071563 1:CAS:528:DC%2BD28Xpt1WitLo%3D (Pubitemid 44330722)
14. H Ulmer C Kelleher G Diem H Concin 2003 Long-term tracking of cardiovascular risk factors among men and women in a large population-based health system: the Vorarlberg Health Monitoring & Promotion Programme Eur Heart J 24 1004 1013 12788300 10.1016/S0195-668X(03)00170-2 (Pubitemid 36712276)
15. J Klenk G Nagel H Ulmer A Strasak H Concin G Diem K Rapp the VHM&PP Study Group 2009 Body mass index and mortality: results of a cohort of 184,697 adults in Austria Eur J Epidemiol 24 83 91 19184464 10.1007/s10654-009-9312-4
16. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds.). Cancer incidence in five continents, vol. VIII. IARC Scientific Publication No. 155, Lyon, 2002
17. Oberaigner W, Vittadello F. Cancer mapping in Alpine regions 1996-2000. Pro Literatur Verlag, Mammendorf, 2006
18. Stocks T, Rapp K, Bjørge T, Manjer J, Ulmer H, Selmer R, Lukanova A, Johansen D, Concin H, Tretli S, Hallmans G, Jonsson H, Stattin P. Blood glucose and risk of incident and fatal cancer in the Metabolic syndrome and Cancer project (Me-Can): analysis of six prospective cohorts. PLoS Med, 6(12): e1000201, 2009. doi: 10.1371/journal.pmed.1000201
19. T Bjørge T Stocks A Lukanova S Tretli R Selmer J Manjer K Rapp H Ulmer M Almquist H Concin G Hallmans H Jonsson P Stattin A Engeland 2010 Metabolic syndrome and endometrial carcinoma Am J Epidemiol 171 892 902 20219764 10.1093/aje/kwq006
20. Häggström C, Stocks T, Rapp K, Bjørge T, Lindkvist B, Concin H, Engeland A, Manjer J, Ulmer H, Selmer R, Tretli S, Hallmans G, Jonsson H, Stattin P. Metabolic syndrome and risk of bladder cancer: prospective cohort study in the Metabolic syndrome and Cancer project (Me-Can). Int J Cancer, 2010. doi: 10.1002/ijc.25521
21. T Bjørge A Lukanova H Jonsson S Tretli H Ulmer J Manjer T Stocks R Selmer G Nagel M Almquist H Concin G Hallmans C Häggström P Stattin A Engeland 2010 Metabolic syndrome and breast cancer in the Me-Can (Metabolic syndrome and Cancer) project Cancer Epidemiol Biomarkers Prev 19 1737 1745 20615887 10.1158/1055-9965.EPI-10-0230
22. T Stocks W Borena S Strohmaier T Bjørge J Manjer A Engeland D Johansen R Selmer G Hallmans K Rapp H Concin H Jonsson H Ulmer P Stattin 2010 Cohort profile: the Metabolic syndrome and Cancer project (Me-Can) Int J Epidemiol 39 660 667 19380371 10.1093/ije/dyp186
23. D Johansen T Stocks H Jonsson B Lindkvist T Bjørge H Concin M Almquist C Häggström A Engeland H Ulmer G Hallmans R Selmer G Nagel S Tretli P Stattin J Manjer 2010 Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580,000 men and women in the Metabolic syndrome and Cancer project Cancer Epidemiol Biomarkers Prev 19 2307 2317 20826833 10.1158/1055-9965.EPI-10-0234 1:CAS:528:DC%2BC3cXhtFart73M
24. Nagel G, Concin H, Bjørge T, Rapp K, Manjer J, Hallmans G, Diem G, Häggström C, Engeland A, Almquist M, Jonsson H, Selmer R, Stocks T, Tretli S, Ulmer H, Stattin P, Lukanova A. Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can). Ann Oncol, 2010 [Epub ahead of print]
25. Stocks T, Lukanova A, Bjørge T, Ulmer H, Manjer J, Almquist M, Concin H, Engeland A, Hallmans G, Nagel G, Tretli S, Veierød MB, Jonsson H, Stattin P. Metabolic factors and the risk of colorectal cancer in 580,000 men and women in the Metabolic syndrome Cancer project (Me-Can). Cancer [Epub ahead of print], 2010
26. Borena W, Stocks T, Jonsson H, Strohmaier S, Nagel G, Bjørge T, Manjer J, Hallmans G, Selmer R, Almquist M, Häggström C, Engeland A, Tretli S, Concin H, Strasak A, Stattin P, Ulmer H. Serum triglycerides and cancer risk in the metabolic syndrome and Cancer (Me-Can) collaborative study. Cancer Causes Control, 2010. doi: 10.1007/s10552-010-9697-0
27. Edlinger M, Strohmaier S, Jonsson H, Bjørge T, Manjer J, Borena WT, Häggström C, Engeland A, Tretli S, Concin H, Nagel G, Selmer R, Johansen D, Stocks T, Hallmans G, Stattin P, Ulmer H. Metabolic syndrome and risk of brain tumour in the large population-based Me-Can cohort study. 2010. [Submitted]
28. Borena W, Strohmaier S, Lukanova A, Jonsson H, Lindkvist B, Bjørge T, Edlinger M, Stocks T, Nagel G, Manjer J, Engeland A, Selmer R, Häggström C, Tretli S, Concin H, Hallmans G, Stattin P, Ulmer H. Metabolic risk factors and primary liver cancer in a large prospective study of 578,700 adults. 2010. [Submitted]
29. AM Strasak K Rapp W Hilbe W Oberaigner E Ruttmann H Concin G Diem KP Pfeiffer H Ulmer the VHM&PP Study 2007 Serum uric acid and risk of cancer mortality in a large prospective male cohort Cancer Causes Control 18 1021 1029 17665312 10.1007/s10552-007-9043-3 (Pubitemid 47237964)
30. AM Strasak K Rapp W Hilbe W Oberaigner E Ruttmann H Concin G Diem KP Pfeiffer H Ulmer on behalf of the VHM&PP Study Group 2007 The role of serum uric acid as an antioxidant protecting against cancer: prospective study in more than 28,000 older Austrian women Ann Oncol 18 1893 1897 17785768 10.1093/annonc/mdm338 1:STN:280:DC%2BD2snmvFSmuw%3D%3D
31. AM Strasak S Lang T Kneib LJ Brant J Klenk W Hilbe W Oberaigner E Ruttmann L Kaltenbach H Concin G Diem KP Pfeiffer H Ulmer the VHM&PP Study Group 2009 Use of penalized splines in extended Cox-type additive hazard regression to flexibly estimate the effect of time-varying serum uric acid on risk of cancer incidence: a prospective, population-based study in 78,850 men Ann Epidemiol 19 15 24 18835524 10.1016/j.annepidem.2008.08.009
32. AM Strasak K Rapp LJ Brant W Hilbe M Gregory W Oberaigner E Ruttmann H Concin G Diem KP Pfeiffer H Ulmer the VHM&PP Study Group 2008 Association of γ-Glutamyltransferase and risk of cancer incidence in men: a prospective study Cancer Res 68 3970 3977 18483283 10.1158/0008-5472.CAN-07-6686 1:CAS:528:DC%2BD1cXlvVOiu7c%3D
33. AM Strasak RM Pfeiffer J Klenk W Hilbe W Oberaigner M Gregory H Concin G Diem KP Pfeiffer E Ruttmann H Ulmer the VHM&PP Study Group 2008 Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women Int J Cancer 123 1902 1906 18688855 10.1002/ijc.23714 1:CAS:528: DC%2BD1cXhtFKgsr7E
34. AM Strasak G Goebel H Concin RM Pfeiffer LJ Brant G Nagel W Oberaigner N Concin G Diem E Ruttmann U Gruber-Moesenbacher F Offner A Pompella KP Pfeiffer H Ulmer the VHM&PP Study Group 2010 Prospective study of the association of serum γ-Glutamyltransferase with cervical intraepithelial neoplasia III and invasive cervical cancer Cancer Res 70 3586 3593 20388786 10.1158/0008-5472.CAN-09-3197 1:CAS:528:DC%2BC3cXltlensrY%3D
35. IS Fentiman DS Allen 2010 γ-Glutamyl transferase and breast cancer risk Br J Cancer 103 90 93 20517309 10.1038/sj.bjc.6605719 1:CAS:528: DC%2BC3cXotFemsbo%3D